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Abstract
Background The increasing number of total hip arthro-
plasties (THAs) performed in younger patients will
inevitably generate larger numbers of revision procedures
for this specific group of patients. Unfortunately, no satis-
fying revisionmethodwith acceptable survivorship 10 years
after revision has been described for these patients so far.
Questions/purposes The purposes of this study were to
(1) analyze the clinical outcome; (2) complication rate; (3)
survivorship; and (4) radiographic outcome of cemented
revision THA performed with impaction bone grafting
(IBG) on both the acetabular and femoral sides in one
surgery in patients younger than 55 years old.
Methods During the period 1991 to 2007, 86 complete
THA revisions were performed at our institution in patients
younger than 55 years. In 34 of these 86 revisions (40%),
IBG was used on both the acetabular and femoral sides in
33 patients. Mean patient age at revision surgery was
46.4 years (SD 7.6). No patient was lost to followup, but
three patients died during followup. None of the deaths
were related to the revision surgery. The mean followup for
the surviving hips was 11.7 years (SD 4.6). We also ana-
lyzed complication rate.
Results The mean Harris hip score improved from 55 (SD
18) preoperatively to 80 points (SD 16) at latest followup
(p = 0.009). Six hips underwent a rerevision (18%): in
four patients, both components were rerevised; and in two
hips, only the cup was revised. Patient 10-year survival rate
with the endpoint of rerevision for any component for any
reason was 87% (95% confidence interval [CI], 67%–95%)
and with the endpoint of rerevision for aseptic loosening,
the survival rate was 97% (95% CI, 80%–100%). In total
six cups were considered radiographically loose, of which
four were rerevised. Three stems were radiographically
loose, of which none was rerevised.
Conclusions IBG is a valuable biological revision tech-
nique that may restore bone stock in younger patients.
Bone stock reconstruction is important, because these pa-
tients likely will outlive their revision implants. Bone
reconstruction with impaction grafting may facilitate future
revisions.
Level of Evidence Level IV, therapeutic study.
Introduction
The increasing number of THAs performed in patients
younger than 55 years will inevitably generate a larger
number of revision procedures for this specific group of
One or more of the authors (WHCR, BWS) certify that they have
received an educational grant of less than USD 10,000 for
instructional course lectures from Stryker-Howmedica (Newbury,
UK) during the study period.
All ICMJE Conflict of Interest Forms for authors and Clinical
Orthopaedics and Related Research1 editors and board members are
on file with the publication and can be viewed on request.
Clinical Orthopaedics and Related Research1 neither advocates nor
endorses the use of any treatment, drug, or device. Readers are
encouraged to always seek additional information, including FDA
approval status, of any drug or device before clinical use.
Each author certifies that his or her institution approved or waived
approval for the human protocol for this investigation and that all
investigations were conducted in conformity with ethical principles of
research.
This study was performed at Radboud University Medical Center,
Nijmegen, The Netherlands.
M. A. J. te Stroet, W. H. C. Rijnen, J. W. M. Gardeniers,
A. van Kampen, B. W. Schreurs (&)
Radboud University Medical Center, Geert Grooteplein 10,
6525 GA Nijmegen, The Netherlands
e-mail: Wim.Schreurs@radboudumc.nl
123




A Publication of  The Association of Bone and Joint Surgeons®
patients. Unfortunately, data on the recent results of revi-
sion THA in younger patients are limited, and survivorship
data from studies of younger patients are not encouraging
[1, 16, 22]. The single long-term survival study reports a
disappointing outcome of 63% at 10 years for patients
when the endpoint was rerevision for any reason [22].
Although the use of highly crosslinked polyethylene and
alternate bearings appears to have reduced the occurrence
of severe osteolysis and bone loss, managing bone loss
represents a substantial challenge in revision hip surgery.
This is particularly true for patients with older designs of
hip implants and for younger patients, because these pa-
tients have a long life expectancy and may require repeated
revisions.
Impaction bone grafting (IBG) is a biological recon-
struction technique that can restore bone defects [19, 33]. It
was first described for the acetabulum in 1984 by Slooff
et al. [31] and subsequently, for the femur, in 1993, by Gie
et al. [14]. Satisfying results have been reported from
several centers with up to 25 years of followup on the
acetabular side [5, 9, 15, 29] and up to 20 years on the
femoral side [13, 21, 26, 32, 34]. In our opinion, the IBG
technique may be a valuable treatment option in revision
THA in patients younger than 55 years.
We therefore chose to analyze the clinical outcome,
complication rate, survivorship, and radiographic outcome
of cemented revisions using impaction allografting on both
acetabular and femoral sides in patients under the age of
55 years.
Patients and Methods
The study was approved by our institutional review board.
All patients were followed up prospectively, and the data
were retrospectively analyzed. Only patients with a mini-
mum followup of 5 years from one single academic center
in The Netherlands were included.
Patients undergoing revision of failed primary THA
inserted for oncologic reasons were excluded. It is our
policy to perform IBG in combination with cemented
components in all revisions with acetabular or femoral
bone stock loss, including in younger patients.
During the period 1991 to 2007, 86 complete THA re-
visions were performed at our institution in patients
younger than 55 years. In 34 of these 86 revisions (40%),
IBG was used on both the acetabular and femoral sides in
33 patients. The 52 other revisions were performed without
IBG or with only acetabular or femoral IBG.
The mean age of the 19 women and 14 men at the time
of the revision surgery was 46.4 years (SD 7.6). One
woman was operated on both hips. The mean weight of the
patients at the time of the surgery was 78.4 kg (SD 16.7);
mean height was 172 cm (SD 10); and the mean body mass
index was 26.4 kg/m2 (SD 5.1). Eighteen procedures (55%)
were performed on the right side.
At the time of our latest review (January 2013), no pa-
tient had been excluded or was lost to followup. Three
patients died during the study—two after 4 years and one
after 7 years of followup (9%); none of the deaths was
related to the surgery and data for the three patients were
included in our final analyses. The mean followup of the
surviving hips was 11.7 years (SD 4.7).
The indication for the primary THA was trauma in 13
hips, osteoarthritis (OA) after childhood hip diseases in
seven hips, primary OA in four hips, OA secondary to
osteonecrosis in three hips, rheumatoid arthritis in three
hips, septic coxitis in one hip, coxitis tuberculosa in one
hip, and unknown for two hips.
The indication for revision was aseptic loosening of both
components in 19 hips, septic loosening in 14, and, in one,
stem malpositioning with aseptic loosening of the cup.
In 19 hips this was the first revision procedure, nine hips
already were revised once or more in our department, and
six hips were already revised in another hospital. All of
these earlier revisions were for aseptic reasons.
It was the first acetabular revision in 22 hips, the second
in 10, and the third in two. On the femoral side, it was the
first revision in 26 hips and the second in eight hips.
Twelve of 14 hips with septic loosening were treated
with a two-stage procedure; all patients were given sys-
temic antibiotics guided by the intraoperative cultures for
at least 6 weeks before reimplantation. The diagnosis of
septic loosening in the remaining two hips was based on
bacterial cultures taken during a one-stage revision for
what had been thought to be aseptic loosening. These two
patients also were treated with systemic antibiotics.
Four surgeons participated in this study; two of the au-
thors (JWMG, BWS) performed 20 and 11 reconstructions,
respectively.
The surgical technique of IBG has been described in
detail before for both the acetabular [30] and femoral [28]
sides. In all hips, a posterolateral approach was used. If
infection was suggested, a two-stage revision was per-
formed. Segmental acetabular and femoral bone defects
were reconstructed using metal meshes and wires. In ac-
etabular reconstructions, a medial wall mesh was used in
three; in 15, a rim mesh; and in 10, a combination of both.
Femoral reinforcement with a metal mesh, screws, and
cerclage wires was used for the proximal femur in seven
patients, the distal femur in one, and a combination of both
in two patients. On the acetabular side, between one and
four fresh-frozen femoral head allografts were used; and on
the femoral side, between one and three. All femoral re-
visions were performed with the X-change1 femoral
revision system (Stryker-Howmedica, Newbury, UK). In
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30 reconstructions, a normal length, polished, tapered Ex-
eterTM component (Stryker-Howmedica) was used, and in
four, a longer Exeter component (C 205 mm) was re-
quired. The acetabular components used were a Muller1
cup (Sulzer, Wintherthur, Switzerland) in 12 hips, an Ex-
eterTM RSA cup (Stryker-Howmedica) in eight hips, an
Exeter ContemporaryTM flanged cup in seven hips, an
Exeter ContemporaryTM hooded cup in six hips, and a
Charnley1 Elite plus cup (DePuy, Leeds, UK) in one hip.
Average duration of the reconstruction surgeries was
4.01 hours (range, 2.32–6.15 hours [ie, incision to close
time]). The antibiotic-loaded bone cement used in all hips
was Surgical Simplex1 (Stryker-Howmedica) containing
erythromycin and colistin.
The postoperative drug regimen included systemic ad-
ministration of antibiotics given after obtaining the cultures
(three intravenous doses of 1 g cefazolin) for 1 day. In-
domethacin was used for 7 days to prevent heterotopic
ossification. All patients received anticoagulation therapy
for at least 6 weeks.
The postoperative physiotherapy protocol changed during
the years. In general, in the first revisions, patients were on
bed rest for 6 weeks with passive movement of the operated
hip starting 24 hours postoperatively. During the next
6 weeks, toe-touch weightbearing was allowed, and during
the last 6 weeks, patients were permitted to load 50% body
weight on the affected hip with use of two crutches. As a
result of increased experience with the IBG technique, the
duration of bed rest was reduced, and currently, patients start
toe-touch weightbearing 1 day after surgery.
All patients were seen at 6 weeks, 3 months, 6 months,
and 12 months postoperatively and then annually or bian-
nually at our institution. All clinical and functional scores
were obtained by an independent research assistant.
Clinical evaluation was prospectively performed using
the Harris hip score (HHS: worst score 0, best score 100)
[18], the Oxford hip score (OHS: worst score 0, best score
48) [25], and the visual analog scales (VAS) [3] for pain at
rest and pain during physical activity—using a scale from 0
(no pain) to 100 (unbearable pain). All patient scores were
determined during postoperative followup, and the HHS
was also determined preoperatively. The scores provided
here were from the latest followup visit.
A complete set of radiographs was available for 33
(97%) of the 34 hips. Bone stock defects were classified
based on both preoperative radiographs and intraoperative
findings using the classification as described by Paprosky
et al. for the acetabular side [27] and by Della Valle and
Paprosky for the femoral side [8] (Table 1). All radio-
graphs were scored on a consensus basis by two of the
authors (MAJS, BWS). Radiolucencies of C 2 mm were
scored around the acetabular component in the three zones
of DeLee and Charnley [7] and on the femoral side with
use of the seven zones described by Gruen et al. [17].
Migration or tilting of the acetabular component was esti-
mated in relation to the line between the teardrops [12].
Femoral subsidence was determined with the method of
Fowler et al. [10]. When radiolucent lines C 2 mm wide
were present in all three acetabular or seven femoral zones,
component migration was C 5 mm, and/or tilting was
C 5, the component was considered radiographically
loose. Trabecular incorporation was evaluated with use of
the criteria of Conn et al. [6], defined as equal radiodensity
of graft and host bone with a trabecular pattern throughout.
We performed Kaplan-Meier survivorship analyses, in-
cluding 95% confidence intervals (CIs), for the complete
revision THAs (acetabular and femoral component) con-
sidering any rerevision of one of the components a
‘‘failure.’’ The endpoints used were rerevision of one or
both components for any reason, for aseptic loosening, and
reoperation for any reason. Patient survival outcomes for
all endpoints were also determined separately for both the
acetabular and femoral components. We used Wilcoxon
rank sum test to compare pre- and postoperative HHS.
Results
Clinical Outcomes Scores
The mean HHS had improved from 55 (SD 18) preop-
eratively to 80 points (SD 16) at latest followup
(p = 0.009). The mean postoperative OHS was 36 (SD 10).
The mean postoperative VAS score for pain at rest was 12
(SD 21) and for pain during exercise 26 (SD 31).
Complications/Reoperations
Intraoperative Complications
Six of 34 (18%) revision procedures were complicated by
an intraoperative fracture with two (6%) on the acetabular
side during the impaction process and four (12%) on the
femoral side during removal of the removal of the old stem
or cement.
Rerevisions, Reoperations, and Other Postoperative
Complications
Nine of 34 hips (26%) underwent one or more reoperations
after the index revision procedure, including six (18%)
revision procedures and three (9%) irrigation and
de´bridements. Of the nine procedures, four were performed
for septic complications (12% of all hips), three were
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performed for aseptic component loosening (9%), one for
traumatic loosening (3%), and one for recurrent instability
(3%). Of the five nonseptic procedures, two were compli-
cated by subsequent periprosthetic infection. During
followup, a rerevision was performed in six patients (18%);
in four patients, both components were rerevised, and in
two patients, only the cup was revised (Table 2).
Three patients underwent de´bridement and antibiotic
therapy for reinfections after index two-stage revision
performed for septic loosening. These three reconstructions
are still in situ and the patients are functioning well,
although they use suppressive antibiotics.
Two patients experienced dislocations. One patient was
treated conservatively with success and the other patient
was treated with a femoral revision for stem malpositioning
with recurrent instability.
One patient had a fracture of the greater trochanter after
a fall, which could be treated conservatively.
Survivorship
Kaplan-Meier analysis showed that the survival rate of the
revision THA with rerevision of one or both components
for any reason as the endpoint was 87% (95% CI, 67%–
95%) at 10 years (Fig. 1A). With rerevision of one or both
components for aseptic loosening as the endpoint, patient
10-year survival was 97% (95% CI, 80%–100%; Fig. 1B)
and with reoperation for any reason as the endpoint 78%
(95% CI, 59%–89%; Fig. 1C). We also analyzed the sur-
vival rate for different periods of followup and for the
separate acetabular and femoral components (Table 3).
Table 1. Classifications—preoperative bone stock defects
Type Definition Number of
hips at risk (%)
Acetabular defects as described by Paprosky et al. [27]
1 Minimal destruction of the acetabular rim and bone lysis localized to cement anchor holes 3 (9)
2A Generalized enlargement of the acetabulum with minimal osteolysis of the dome and slight superior and
medial migration of the cup
7 (20)
2B Similar to type 2A defects, but more destruction of the dome is present 14 (41)
2C Defects involve destruction of the medial wall with generalized rim enlargement 3 (9)
3A Bone loss patterns involve the superior rim of the acetabulum from the 10 o’clock to the 2 o’clock
position and often display medial wall deficiency
4 (12)
3B Similar to type 3A defects, but the rim defects span from 9 o’clock to the 5 o’clock position 3 (9)
Femoral defects as described by Della Valle and Paprosky [8]
1 Minimal loss of metaphyseal cancellous bone with an intact diaphysis 8 (23)
2 Extensive loss of metaphyseal bone with an intact diaphysis 17 (50)
3A The metaphysis is damaged severely and nonsupportive; a minimum of 4 cm of intact cortical bone is
present in the femoral isthmus
6 (18)
3B The metaphysis is severely damaged with some intact cortical bone present distal to the isthmus (\ 4 cm) 1 (3)
4 Extensive metadiaphyseal damage in conjunction with a widened femoral canal 2 (6)
Table 2. Indications for rerevision in six patients
Components rerevised Indication for rerevision Followup (years)
4 rerevisions of both the
acetabular and femoral
component
1 aseptic loosening 11.7
1 septic loosening (conversion to permanent excision arthroplasty) 3.6
1 stem rerevision for malpositioning causing recurrent dislocations 1.6
(with later rerevision of both components for septic loosening) 2.9
1 cup rerevision for traumatic loosening after fall 8.7
(with later rerevision of both components for septic loosening) 9.8
2 cup rerevisions 2 aseptic loosenings 2.6 and 10.8




Radiolucencies were observed around 12 cups (35%). In
four cups, radiolucencies were seen in all three zones; three
of the four cups were rerevised; the fourth patient was
chronically infected. Four cups had radiolucencies in two
zones; one of these was rerevised. Five nonrerevised cups
had radiolucencies in one zone.
In six hips, migration and/or tilting of the cup was ob-
served; four of these were rerevised. The other two cups
gradually tilted 5 and 13, the latter, again, a chronically
infected patient.
So, in total six cups were considered radiographically
loose, of whom four were rerevised. In the nonrerevised
acetabula, trabecular incorporation could be scored in 83 of
84 (99%) zones; one was obscured by a metal mesh. In 70
of 83 zones (84%), incorporation was seen.
Femoral Side
Radiolucencies were observed around 11 stems (32%);
these were seen in one zone in five patients, in two zones in
five patients, and in five zones in one patient. The mean
subsidence of the stem within the cement mantle was
2.6 mm (range, 0–8.8 mm). Three stems subsided between
5 and 10 mm. In two of these, the subsidence was pro-
gressive. None of these three stems needed rerevision. In
the nonrerevised hips, 198 of the total 210 Gruen zones
(94%) could be scored for trabecular incorporation; 12
zones were obscured by metal meshes. Incorporation
(Fig. 2) was seen in 181 of the 198 zones (91%).
Discussion
The increasing number of THAs performed in younger
patients will inevitably generate a larger number of
Fig. 1A–C Kaplan-Meier survival curve shown for complete revision THAs (acetabular and femoral components) with (A) rerevision for any
reason; (B) rerevision for aseptic loosening; and (C) reoperation for any reason of one or both components as the endpoint.
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revision procedures in this group of patients. This is the
first study that describes satisfying results of revision THA
performed in patients aged\ 55 years. This study fills a
gap in the revision THA literature, because the reported
results in younger patients have been disappointing until
now [1, 16, 22]. The 10-year survivorship was 97% for
rerevision for aseptic loosening and 87% for rerevision for
any reason.
This study has a number of limitations. First, it was
impossible to radiographically evaluate trabecular incor-
poration in a number of acetabular (1%) and femoral (6%)
zones that were treated with extensive reconstruction with
meshes. However, we did not find a difference in clinical or
survivorship outcomes for these cases. Additionally, also
the evaluation if a component is radiographically loose,
sometimes is difficult when using this revision technique.
Nevertheless, with the criteria we defined for component
loosening, we were able to assess the loosening of the
components adequately. Second, we were missing patient
preoperative OHS and VAS scores because during the early
phase of the study, our structured preoperative screening
was still in the developing stage. Third, our number of
patients seems to be relatively small. Nevertheless, the
clinical outcome of all patients had been reported, resulting
in a loss-to-followup quotient of zero, which is, according
to Murray et al. [24], ideal. Also the radiographic followup
was nearly complete (97%). We chose to study only those
patients who had complete IBG revision of both the ac-
etabular and femoral sides in one surgery because the
outcome of only a cup or stem revision will always be
Table 3. Survival for different followup times and endpoints













Survival complete revision THA (acetabular and femoral component)
Rerevision for any reason (events = 6) 91% (75–97) 28 87% (68–95) 18 75% (51–89) 5
Rerevision for aseptic loosening (events = 3) 97% (80–100) 28 97% (80–100) 18 84% (57–95) 5
Reoperation for any reason (events = 9) 82% (64–92) 25 78% (59–89) 18 68% (46–82) 5
Survival acetabular components only
Rerevision for any reason (events = 6) 91% (75–97) 28 87% (68–95) 18 75% (51–89) 5
Rerevision for aseptic loosening (events = 3) 97% (81–100) 28 97% (81–100) 18 84% (57–95) 5
Reoperation for any reason (events = 9) 82% (64–92) 25 78% (59–89) 18 68% (46–82) 5
Survival femoral components only
Rerevision for any reason (events = 4) 94% (78–98) 29 89% (69–97) 18 83% (58–94) 6
Rerevision for aseptic loosening (events = 1) 100% 29 100% 18 93% (59–99) 6
Reoperation for any reason (events = 7) 85% (68–94) 26 81% (62–91) 18 75% (53–88) 6
CI = confidence interval.
Fig. 2A–C (A) Preoperative radiograph of a female patient, about to
undergo THA, showing aseptic loosening and bone loss of both the
acetabulum and proximal femur. The patient had previously under-
gone total cemented revision implantation. The revision components
were in situ for 11 years. The patient was 19 years old when the
primary total hip prosthesis was implanted after a coxitis. The
primary THA was revised after 15 years. (B) Radiograph after the
index revision surgery with IBG of both the acetabulum and the
femur. The patient was 45 years old at the time of the revision.
Segmental bone defects of the medial and lateral acetabular wall were
reconstructed with metal meshes and screws. On the femoral side, a
distal cortical perforation was covered with a metal mesh and cerclage
wires, and the dorsal calcar region was also reconstructed. (C)
Radiograph at final followup 19 years after the index revision with
IBG. Both revision implants are stable with incorporation of the bone
grafts, although a small osteolytic area can be seen in Gruen Zone 1 of
the femur. The patient was 64 years old at last followup and still has
an excellent functioning hip (HHS 95) 45 years after the first THA.
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influenced by the component left in situ at the partial re-
vision. Fourth, in the majority of the included revisions, no
extensive bone stock defects were present. When we had
included only patients with Paprosky grades[ 3 on both
the acetabular and femoral sides, the results would prob-
ably have been worse than now.
The mean HHS at final followup in our study had im-
proved 25 points. This comparable to the improvement in
clinical scores reported by other revision series performed
in younger patients. Adelani et al. [1] reported a mean
improvement in HHS of 19.2 points and Lee et al. [22]
reported an improvement of 36 points in the modified HHS
(no physical examination is necessary for this modified
scoring system).
Regarding the postoperative complications, we reported
a postoperative periprosthetic fracture in one patient (3%),
dislocations in two patients (6%), and a reoperation for a
deep infection in four patients (12%). Of the studies on the
revision THAs in young patients, only Lee et al. [22]
specified their postoperative complications. They observed
10 periprosthetic fractures (5.5%), 11 dislocations (6.1%),
and two deep infections (1.1%). An explanation for the
high percentage of reoperations for infections in our study
could be the relatively high percentage of index revisions
that were performed for septic loosening (14 procedures
[41%]). Our hospital is a tertiary referral center for the
treatment of prosthetic infections and complex hip surgery.
As a result, in our study group of younger patients, the
indication for primary THA in only four patients was
standard with primary OA. Most patients had undergone
more than one previous operation on their hip for trau-
matic, congenital, or other complex hip problems before
the index revision was performed. The mean number of
previous operations was 4.3 for the 14 septic revisions
compared with two for the 20 aseptic revisions. This higher
number of previous operations certainly can explain the
high rate of infectious cases.
In two patients, an acetabular fracture occurred during
the impaction process (6%). Once recognized, this problem
can be solved by fracture fixation using an additional plate
or mesh. These fractures have not deteriorated the outcome
as was shown in our study. One of the patients functioned
well but died 4 years after the revision; the other patient
still has a stable reconstruction 9 years after surgery. Un-
fortunately, none of the previous revision studies in young
patients specified their intraoperative complications mak-
ing a comparison impossible.
When we compare the survival outcomes, the multi-
center trial published by Girard et al. [16] reported a
disappointing 10-year survivorship of 36% for the endpoint
rerevision for any reason (77 revisions in 55 patients
aged\ 30 years). In only 21 revisions both components
were exchanged and these patients were extremely young.
Adelani et al. [1] performed a case-controlled study of 103
mostly uncemented revisions compared with 103 primary
THAs. Patients accounting for 43 other revisions per-
formed during the study period were lost to followup
(29.5%). At a mean followup time of 6.7 years, 71 revi-
sions (69%) survived compared with 102 (99%) primary
THAs. However, only 11 of 103 revisions including both
components were revised. Lastly, Lee et al. [22] recently
published their results of 181, mostly uncemented revisions
(of which 109 were complete revisions) in 102 patients
aged 50 years or younger after a mean followup of
11 years. Unfortunately, 27 patients were lost to followup
before the minimum of 2 years (and therefore only in-
cluded in the survival analysis) and the radiographs of 67
patients were lost. The 10-year survival for endpoint
rerevision for any reason was 63%. The authors suggested
that bone grafting could be a reasonable option to further
improve the outcome in this group of younger patients. It
seems that the 10-year results of our cemented IBG revi-
sions are at least comparable to the results of all these
studies.
Radiological interpretation of graft incorporation in IBG
remains difficult, despite the criteria defined by Conn et al.
[6]. Incorporation can only be proven histologically. In a
study based on 24 human acetabular biopsies taken
between 1 month and 15 years after reconstruction,
revascularization and incorporation of the bone graft were
generally seen [33]. Most cases showed lamellar bone with
few graft remnants. Also in a human retrieval, Heekin et al.
[19] reported complete incorporation of morsellized allo-
graft on the acetabular side. We could score radiographic
signs of trabecular incorporation in 84% of the acetabular
zones and 91% of the femoral zones in the surviving hips.
In other studies performed with bone impaction grafting,
Emms et al. [9] reported union of the graft in 64 of the 67
surviving acetabular reconstructions performed with irra-
diated allografts (95.5%) and Wraighte and Howard [34]
reported radiographic evidence of trabecular incorporation
in 87% of the Gruen zones that they could evaluate in 75
femoral bone impaction grafting revisions. Comparison of
our radiographic results with the results of other revision
series in young patients unfortunately is not possible, be-
cause in all these three studies, no radiographic results are
described.
Next to IBG, other treatment modalities could be of use
in revision THAs in young patients. In case of large ac-
etabular defects jumbo cups [20] or modified cup shapes [4,
23] are possible treatment options. Also custom-made
implants can be promising, although only short-term results
have been reported until now [11]. In cases with femoral
bone stock loss for example, cementless modular stems [2]
can be inserted. However, when using all these techniques,
the bone stock loss is not replenished and none of these
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techniques up until now have been reported to produce
good results in a specific young patient group.
In conclusion, IBG is a valuable biological revision
technique that may restore bone stock with satisfying long-
term results and seems to be an especially beneficial option
in younger patients because of their longer life expectancy.
Younger patients will even outlive their revision implants
and, hence, face future revisions. The amount of bone stock
is essential to facilitate future revisions in these still
relatively young patients.
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